NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for concurrent therapy


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data from University of Texas, Department of Clinical Sciences advance knowledge in life sciences
2009 NOV 23 ... lower remission rates after that point. Treatment resistance was associated with more concurrent axis I or III co-morbid conditions, socioeconomic disadvantage, chronicity and ... There were no significant differences in remission in step 2 between cognitive therapy and medication treatment in either the switch (31% vs 27%) or augmentation (31% vs 33%) ...
Subject: Life Sciences
Price: $3.00
*
Data on head and neck cancer therapy discussed by researchers at University of Ulsan
2009 NOV 23 ... lymphoma of the head and neck. Six patients received RT only, and five patients received concurrent chemoradiotherapy. All patients showed improvements in their oral mucositis after ... chemotherapy and who had developed severe oral mucositis (higher than the Radiation Therapy Oncology Group grade 3) were treated with topical rhEGF twice daily for 7 days. The ...
Subject: Head and Neck Cancer Therapy
Price: $3.00
*
Findings from H.M. Peto and co-authors broaden understanding of HIV/AIDS co-infection
2009 NOV 23 ... meningeal, peritoneal, and unclassified EPTB cases. We excluded cases with concurrent extrapulmonary-pulmonary tuberculosis and cases of disseminated (miliary) tuberculosis. ... Diseases, Mycobacteria, Mycobacterium Tuberculosis, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology. This article was prepared by AIDS Weekly ...
Subject: HIV/AIDS Co-Infection
Price: $3.00
*
Findings from S. Berning and co-authors provide new insights into epilepsy
2009 NOV 23 ... regarding sociodemographic data, type, etiology, onset and duration of SE, dose of LEV, concurrent antiepileptic drugs (AED) treatment, tolerability, and outcome. Thirty-two patients (15 ... was acute 13 times and remote symptomatic 16 times; three SE were of unknown etiology. Therapy was initiated within a median time of 3 h and LEV i.v. was applied within a median time ...
Subject: Epilepsy
Price: $3.00
*
New cervical cancer findings from University Hospital published
2009 NOV 23 ... 0.265). Patients aged 55 years or older with locally advanced cervical cancer undergoing concurrent weekly cisplatin with pelvic radiation on cooperative group clinical trials achieve ... Brachytherapy, Cervical Cancer, Cervical Carcinoma, Chemotherapy, Cisplatin, Drug Therapy, Drugs, Gynecology, Oncology, Pharmaceuticals, Treatment, Women's Health, University ...
Subject: Cervical Cancer
Price: $3.00
*
New infarction study findings have been reported by researchers at RIKEN
2009 NOV 16 ... and recovery from MI and exhibits a significant and dose-dependent potential for concurrent cardiomyogenesis and vasculogenesis. (Arterioscler Thromb Vasc Biol. 2009; ... Biotechnology, Biotherapy, Blood Transfusion, Cardiology, Cardiovascular, Cell Therapy, Cord Blood, Echocardiography, Fibrosis, Heart Attack, Hematology, Hepatology, ...
Subject: Infarction
View Free
Daily News
Article
New laryngeal cancer research from Kyorin University, Medical Department described
2009 NOV 16 ... Kogashiwa and colleagues published their study in Oncology Reports (Concurrent chemoradiotherapy for organ function preservation in advanced patients with ... cases with histologically proven squamous cell carcinoma undergoing function-preserving therapy were examined. Induction chemotherapy comprised cisplatin and 5-fluorouracil, and ...
Subject: Laryngeal Cancer
Price: $3.00
*
New non-small cell lung cancer therapy study findings have been reported from National Cancer Center Hospital
2009 NOV 23 ... in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy,' are detailed in a study published in Japanese Journal of Clinical ... Oxford OX2 6DP, England. Keywords: Japan, Tokyo, Non-Small Cell Lung Cancer Therapy, Adenocarcinoma, Body Weight, Chemotherapy, Clinical Oncology, Drug Therapy, Gender ...
Subject: Non-Small Cell Lung Cancer Therapy
Price: $3.00
*
New Results from Study for Monitoring Antimicrobial Resistance Trends (SMART) Show Rates of In Vitro Susceptibility of E. coli Isolates to Commonly Used Antibiotics
2009 NOV 16 ... urinary tract infections, including pyelonephritis, due to E. coli, including cases with concurrent bacteremia, or K pneumoniae. Appropriate specimens for bacteriological ... and identify the causative organisms and to determine their susceptibility to INVANZ. Therapy with INVANZ may be initiated empirically before results of these tests are known; once ...
Subject: Urinary Tract Infection
Price: $3.00
*
New tachycardia research from University of Cambridge outlined
2009 NOV 16 ... on rabbit left atria and right ventricular papillary muscles. Cilostamide and concurrent cilostamide + rolipram, but not rolipram alone, increased sinoatrial rate by 15% and 31% ... Medical Device, Neurology, Pacemakers, Pharmaceuticals, Pharmacology, Tachycardia, Therapy, Treatment, University of Cambridge. This article was prepared by Pain & ...
Subject: Tachycardia
Price: $3.00
*
Reports from Medical University of South Carolina add new data to research in cancer
2009 NOV 16 ... of PDI results in alterations in the alpha-helix content of PDI and is concurrent with inhibition of its isomerase activity," wrote D.M. Townsend and colleagues, Medical ... Oxide, Oncology, Pancreas, Pharmaceuticals, Protein Processing, Proteins, Proteomics, Therapy, Treatment, Medical University of South Carolina. This article was prepared ...
Subject: Cancer
Price: $3.00
*
Research reports from J. Gruenwald and co-authors provide new insights into osteoarthritis
2009 NOV 23 ... B. There was a tendency toward superiority shown in the secondary target criteria and concurrent variables. In the global safety evaluation, both products have been demonstrated to be ... alone ( group B)," scientists in Berlin, Germany report. "The primary therapy evaluation was performed using the Western Ontario and McMaster Universities Arthrosis ...
Subject: Osteoarthritis
Price: $3.00
*
Research results from F. Benazzi and colleagues update understanding of bipolar disorder
2009 NOV 23 ... as >= 50% reduction in Montgomery-Asberg Depression Rating Scale score and < 2 concurrent manic/hypomanic symptoms. Switching to mania/hypomania was defined as a YMRS score >= ... Manic-Depressive Illness, Mental Health, Olanzapine, Pharmaceuticals, Psychiatry, Therapy, Treatment. This article was prepared by Biotech Business Week editors from ...
Subject: Bipolar Disorder
Price: $3.00
*
Researchers from Cleveland Clinic detail findings in cancer
2009 NOV 23 ... "Mature results are presented from a phase II trial of postoperative concurrent chemoradiotherapy in patients with poor-prognosis cancer of the esophagus and ... Carcinoma, Fluorouracil, Gastroenterology, Oncology, Pharmaceuticals, Surgery, Therapy, Treatment, Cleveland Clinic. This article was prepared by Biotech Business ...
Subject: Cancer
Price: $3.00
*
Researchers from Vanderbilt University detail findings in cancer
2009 NOV 16 ... therapy also significantly decreases tubule formation. These results suggest that concurrent induction of apoptosis and autophagy enhances radiation therapy both in vitro and in ...
Subject: Cancer
Price: $3.00
*
Specialty Medical Coatings Evolving to Meet Medical Device Challenges
2009 NOV 16 ... among designers, manufacturers, and developers. First-line development concepts such as concurrent engineering and design for manufacturing are becoming the rule rather than the ... Data Research Keywords: Bacterial Infections, Diagnostics, Hematology, Therapy, Thrombosis, Treatment, Applied Data Research. This article was prepared by ...
Subject: Thrombosis
Price: $3.00
*
Studies from M.B. Jimenez and colleagues provide new data on irritable bowel syndrome
2009 NOV 23 ... colonizing the gastrointestinal tract by binding to the intestinal and colonic mucosa. Concurrent with colonization by Lp there is a decrease in bacterial groups with gas-producing ... compare because of differences in study design, probiotic dose, strain, and duration of therapy, some studies show symptom improvement. Lactobacilli are found among the normal ...
Subject: Irritable Bowel Syndrome
Price: $3.00
*
Studies from M.F. Kalady and co-researchers in the area of recurrence published
2009 NOV 23 ... between 1997 and 2007 were identified from a single-institution Sixty-four patients with concurrent inflammatory bowel disease, bereditary colorectal cancer, other malignancy, urgent ... and tumor factors influence pCR, an extended interval between completion of neoadjuvant therapy and surgery was the single most important determinant in achieving a pCR." ...
Subject: Recurrence
Price: $3.00
*
Study findings from G.B. Roldan et al broaden understanding of life sciences
2009 NOV 16 ... have identified GBM patients who experienced transient radiological deterioration after concurrent chemoradiotherapy which stabilized or resolved after additional cycles of adjuvant TMZ, ... Calgary, Life Sciences, Oncology, Glioblastoma, Temozolomide, Pharmaceuticals, Drugs, Therapy, Treatment. This article was prepared by Biotech Business Week editors from ...
Subject: Life Sciences
Price: $3.00
*
Study finds it's safe to treat HER2-positive breast cancer with trastuzumab and adjuvant radiation
2009 NOV 16 ... "Our study evaluated the skin toxicity and early cardiac toxicity of concurrent Trastuzumab and radiation therapy treatment in the adjuvant setting," says Penny ...
Subject: Fox Chase Cancer Center
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login